Moreover, the activation of PPARdelta induces neuroprotection and reverses neurodegeneration in Alzheimer’s disease (Tong et al., 2016), Parkinson’s disease (Martin et al., 2013) and Huntington’s disease (Dickey et al., 2016). This evidence concerns the gene PPARD and Alzheimer disease.